Sales Growth YoY (Last 12 Months): Theriva Biologics, Inc. (TOVX)

Public company logo of Theriva Corp (TOVX)

Theriva Biologics, Inc. (TOVX) adheres to ESG principles by strictly controlling biohazardous waste and research ethics. The sales dynamics over the last 12 months year-over-year demonstrate current trends, where the 0.00 indicator expresses the state of the metric. The financial stability of Theriva Biologics, Inc. (TOVX) depends on grants and test outcomes in the absence of stable revenue, although the company successfully retains its staff of leading oncologists and experts.

Theriva Biologics (TOVX) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/19/2026

Theriva Biologics (TOVX) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Theriva Biologics, Inc.
Product sample of therivabio.com

Assessing the financial stability of Theriva Biologics, Inc. (TOVX) requires an analysis of the company's ability to generate revenue against the backdrop of colossal R&D expenditures and stringent FDA oversight. The rolling year-over-year sales growth trajectory measures the percentage change in revenue over the last 12 months relative to the previous period, allowing investors to evaluate the commercial viability of the biotechnologies under high regulatory pressure.

Competitors of Theriva Biologics, Inc. (TOVX)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) liminatuspharma.com|Sales Growth YoY (Last Twelve Months) LVTX|Revenue Growth YoY (Last 12 Months) NXTC (NextCure, Inc.)|LPTX: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Trailing Twelve Months Revenue Growth|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)